FAILURE OF GANCICLOVIR TREATMENT ASSOCIATED WITH SELECTION OF A GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS STRAIN IN A LUNG TRANSPLANT RECIPIENT
Sophie Alain(Université de Limoges), Marie‐Christine Mazeron(Université Paris Cité), Marie-José Sanson-Le Pors(Hôpital Lariboisière), Christophe Vadam(Hôpital Lariboisière), M. Stern(Hôpital Foch), P. Honderlick(Hôpital Foch), D. Grenet(Hôpital Foch)
Cited by 65
Related Papers
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
Bacterial Populations Contaminating The Upper Gut in Patients With Small Intestinal Bacterial Overgrowth Syndrome
|The American Journal of Gastroenterology|1999|196
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2021|185
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
|Journal of Antimicrobial Chemotherapy|2010|163